IPCALAB — Ipca Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Ipca Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13,701	21,801	8,454	11,051	12,157
Net Total Accounts Receivable
Net Total Receivables	11,531	11,962	19,271	21,927	20,641
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	44,572	51,893	55,389	59,670	63,736
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,026	26,946	46,632	46,853	52,024
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	76,235	86,264	111,013	117,606	123,702
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14,659	18,058	23,556	23,862	23,069
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	21,587	27,844	47,691	48,121	43,064
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	54,648	58,420	63,322	69,485	80,638
Total Liabilities & Shareholders' Equity	76,235	86,264	111,013	117,606	123,702
Total Common Shares Outstanding